题名 |
WISH (WGM-101)血糖機驗證之評估研究 |
并列篇名 |
The Evaluation Study of Verification for WISH (WGM-101) Glucometer |
作者 |
商弘昇(Hung-Sheng Shang);陳清梅(Ching-Mei Chen);黃正一(Zheng-Yi Huang);闕宗熙(Tzong-Shi Chiueh);張錦標(Jin-Biou Chang) |
关键词 |
WISH(WGM-101)血糖機 ; 驗證 ; 糖尿病 ; WISH (WGM-101) glucometer ; verification ; diabetic mellitus ; ISO 15197:2003 |
期刊名称 |
中華職業醫學雜誌 |
卷期/出版年月 |
21卷2期(2014 / 04 / 25) |
页次 |
111 - 122 |
内容语文 |
繁體中文 |
中文摘要 |
Purpose: WISH (WGM-101) is a new development of glucometer. The pre-marketing clinical verification of glucometer could ensure the quality in diabetic patients when self-monitoring of blood glucose and provide accurate and reliable data.Method: ISO 15197:2003 is a verified norm for small glucometer in EU countries. Verification includes: precision evaluation, accuracy evaluation, comparative correction evaluation, users evaluation, interference evaluation, linear evaluation. Test results could meet international ISO15197: 2003 requirements.Results: The results of the precision is SD 0.6-2.1 (SD<5.0 mg/dL) when blood glucose concentration is <75 mg/dL and CV 2.2-4.8% (CV<5.0%) when blood glucose concentration is ≥75 mg/dL. The SD and CV are 0.3-4.8% and 1.2-2.9 of Within-run、The SD and total CV are 0.8-3.3% and 0.8-5.8% of Between-day. There are more than 95% of accuracy within ±20% error range and mean bias is 12.81mg/dL. There are 98%~100% in zone A for Clarke Grid evaluation and 0%~2% in zone B. The evaluation of comparative correction is 100% in zone A. There are 98% of users evaluation in zone A and 2% in zone B. Interference evaluation includes 6 common drugs in clinical practice and 2 sources of interference produced by body. The results show that 8 interferences caused by the error are less than ±10% and at least 95% results are within error range. The liner range of the evaluation is 40-563mg/d.Conclusion: The results of the verification for WISH (WGM-101) glucometer fulfill International ISO 15197:2003 requirement. |
英文摘要 |
Purpose: WISH (WGM-101) is a new development of glucometer. The pre-marketing clinical verification of glucometer could ensure the quality in diabetic patients when self-monitoring of blood glucose and provide accurate and reliable data.Method: ISO 15197:2003 is a verified norm for small glucometer in EU countries. Verification includes: precision evaluation, accuracy evaluation, comparative correction evaluation, users evaluation, interference evaluation, linear evaluation. Test results could meet international ISO15197: 2003 requirements.Results: The results of the precision is SD 0.6-2.1 (SD<5.0 mg/dL) when blood glucose concentration is <75 mg/dL and CV 2.2-4.8% (CV<5.0%) when blood glucose concentration is ≥75 mg/dL. The SD and CV are 0.3-4.8% and 1.2-2.9 of Within-run、The SD and total CV are 0.8-3.3% and 0.8-5.8% of Between-day. There are more than 95% of accuracy within ±20% error range and mean bias is 12.81mg/dL. There are 98%~100% in zone A for Clarke Grid evaluation and 0%~2% in zone B. The evaluation of comparative correction is 100% in zone A. There are 98% of users evaluation in zone A and 2% in zone B. Interference evaluation includes 6 common drugs in clinical practice and 2 sources of interference produced by body. The results show that 8 interferences caused by the error are less than ±10% and at least 95% results are within error range. The liner range of the evaluation is 40-563mg/d.Conclusion: The results of the verification for WISH (WGM-101) glucometer fulfill International ISO 15197:2003 requirement. |
主题分类 |
醫藥衛生 >
醫院管理與醫事行政 |